Table 1.

Summary of clinical time-course.

CAR-T day	+7	+8 to +10	+19	+27	+28	+29	+30 to +60	+61 to +82	+83 to +91	+92 to +107	+108
ALC	40	20–43	2,030	1,030	1,400	920	40–500	100–170
Events	Gr. II CRS; Gr. II ICANS		Re-admit						Pneumonia Resp. failure	Regained enteral access (PEG)	Hemoptysis, Sepsis, Death
MNT status
Immunotherapies	Toci.		IVIg
Steroids	Dex.	Dex.	Dex.	Dex.	Dex.	Dex.	Dex.	Dex.
Dopaminergic therapies					Carbidopa/levodopa (C/L)	C/L	C/L	C/L Ropinirole Amantadine		C/L Ropinirole Amantadine	C/L Ropinirole Amantadine

ALC , Absolute Lymphocyte Count; Dex., Dexamethasone; PEG , Percutaneous Endoscopic Gastrostomy; Toci. , Tocilizumab. Shading represents MNT symptoms, where darker shading represents more severe symptoms.